Breaking News
November 21, 2018 - Vitamin D critical to early development of vertebrates, study suggests
November 21, 2018 - Myriad biological, societal factors that impact CKD severity for children of African descent
November 21, 2018 - Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer
November 21, 2018 - Experts offer more clarity on managing common ankle fractures
November 21, 2018 - About 300 million bits of DNA are missing from basic reference genome, report scientists
November 21, 2018 - Study explores how the moving brain processes visual information
November 21, 2018 - Gut protein mutations protect against spikes in blood glucose levels
November 21, 2018 - First probabilistic atlas of thalamus nuclei to better understand the brain
November 21, 2018 - Peanut allergies could soon have a drug treatment
November 21, 2018 - Vanderbilt researchers isolate antibody that can neutralize West Nile virus
November 21, 2018 - KHN’s ‘What the Health?’ Health nerd books for the holidays
November 21, 2018 - MDMA could help gain trust but does not make one naive find researchers
November 21, 2018 - Study uncovers new mechanism controlling the master cancer regulator
November 21, 2018 - Online communication technologies could stave off depression among seniors, shows study
November 21, 2018 - FDA Approves Gamifant (emapalumab-lzsg) for Primary Hemophagocytic Lymphohistiocytosis
November 21, 2018 - Artificial intelligence predicts treatment effectiveness
November 21, 2018 - A bicyclist’s road to recovery after traumatic brain injury
November 21, 2018 - New research project to combat obesity, type 2 diabetes receives NIH funding
November 21, 2018 - Humans play key role in distribution and transmission of Bartonella bacteria
November 21, 2018 - First modeling system developed for testing age-specific human immune responses to vaccines
November 21, 2018 - FDA Alert: Gilenya (fingolimod): Drug Safety Communication
November 21, 2018 - Uric Acid Test: MedlinePlus Lab Test Information
November 21, 2018 - Researchers use genetics to predict response to antipsychotic medications
November 21, 2018 - Proposal to include the price of drugs in television ads is flawed, Stanford scholar writes
November 21, 2018 - Disrupting reproduction strategy of disease-causing parasites could help fight malaria
November 20, 2018 - ACAAI: Almost 2 Percent of Children Have Milk Allergy
November 20, 2018 - Congenital anomalies of kidney and urinary tract – Genetics Home Reference
November 20, 2018 - Can video games improve the health of older adults with schizophrenia?
November 20, 2018 - Can flicking a molecular switch restore the aging immune system’s competence?
November 20, 2018 - Restek launches new Oregon cannabis pesticide standards
November 20, 2018 - Health sector coalition urges Government to safeguard patients in future UK-EU relationship
November 20, 2018 - Study evaluates second-hand marijuana smoke exposure among children
November 20, 2018 - Scientists identify three genes responsible for recurrent molar pregnancies
November 20, 2018 - Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene
November 20, 2018 - Dining Out With Allergies Is Tough, But These Steps Can Help
November 20, 2018 - Breastfeeding protects infants from antibiotic-resistant bacteria
November 20, 2018 - AI matched, outperformed radiologists in screening X-rays for certain diseases | News Center
November 20, 2018 - Adolescents increasingly choose marijuana over cigarettes, alcohol
November 20, 2018 - World’s first medical imaging scanner produces diagnostic scan of the whole human body
November 20, 2018 - Cytocybernetics receives NIMH award to move into neuronal drug development
November 20, 2018 - Researchers discover new information on pathological mechanisms of Alzheimer’s disease
November 20, 2018 - ‘Unknown’ enzyme may be key to new treatment for inflammatory diseases
November 20, 2018 - Recreational drug may help people regain trust in others
November 20, 2018 - Researchers identify gene vital for post-stroke recovery
November 20, 2018 - Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury
November 20, 2018 - Potential new therapeutic approach developed for synovial sarcoma
November 20, 2018 - Skeletal imitation reveals how bones grow atom-by-atom
November 20, 2018 - Autism behaviors show unique brain network fingerprints in infants
November 20, 2018 - Location matters for inflammation clearance
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Low-protein, high-carb diet may promote healthy brain ageing
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Live probiotics can change existing gut flora and alter immune response
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
Two thyroid medications recalled by FDA

Two thyroid medications recalled by FDA

image_pdfDownload PDFimage_print

The United States Food and Drug Administration (FDA) have announced the recall of two thyroid medications due to issues with their ingredients.

Westminster Pharmaceuticals has recalled the Levothyroxine and Liothyronine tablets as a precautionary measure says the FDA statement. The FDA states that these medications had to be recalled because, “they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s import alert.” Patients taking these medications however are instructed to continue taking them until they have been given a replacement.

The FDA statement says that Westminster Pharmaceuticals has been recalling all lots of the said tablets within their expiry dates. Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg have been recalled to the whole sale level.

The ingredients used to make these tablets have been found to be sourced before the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd. These were thus found to be deficient of the Current Good Manufacturing Practices (cGMP). Lower standards of manufacturing process can put the preparation at risk says the FDA. There have been no reports of any side effects or adverse events among the users of these medications however.

Levothyroxine and Liothyronine (thyroid tablets, USP) are oral tablets that contain thyroid hormone thyroxine. They contain tetraiodothyronine sodium (T4 levothyroxine) and liothyronine sodium (T3 liothyronine). These are prescribed for regular use among patients with underactive thyroid glands or hypothyroidism. There are no serious adverse effects of these medications and they are to be used by the consumers until they are replaced suitably. Stopping them could be dangerous.

Westminster Pharmaceuticals owner and CEO Gajan Mahendiran has said in a statement, “Westminster Pharmaceuticals aims to ensure that integrity is embedded in our reputation through the products we develop and market. We will never compromise when it comes to providing our patients with the caliber of medication they deserve. While we stand behind the quality of our product, we are taking the utmost precaution by recalling our Thyroid, USP Tablets only to the wholesale level due to a recent inspection by the FDA at one of our active ingredient manufacturers.”

At present the recall is for 100-count bottles. Some of the lot numbers and Expiration dates include Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15mg X 100ct (lot numbers 15918VP03, 15918VP02, 15918VP01, 15918007, 15918006, 15918005, 15918004, 15918003, 15918002, 15918001, 15917VP03, 15917VP02, 15917VP01), Levothyroxine and Liothyronine (Thyroid Tablets, USP) 30mg X 100ct (lot numbers 15517VP01, 15517VP02, 15517VP03, 15518001, 15518002), Levothyroxine and Liothyronine (Thyroid Tablets, USP) 60mg X 100ct (Lot numbers 15618011, 15618009, 15618008, 15618004, 15618002, 15617VP06, 15617VP05, 15617VP04, 15617VP03, 15617VP01, 15617VP-02), Levothyroxine and Liothyronine (Thyroid Tablets, USP) 90mg X 100ct (Lot numbers 15717VP-01, 15717VP-02, 15717VP-03, 15718004, 15717002) and Levothyroxine and Liothyronine (Thyroid Tablets, USP) 120mg X 100ct (Lot numbers 15817VP-01, 15817VP-02, 15817VP-03, 15818001).

Westminster at present is notifying the distributers directly by email and phone to stop the distribution of these lots of medications. The impacted products are to be soon returned to Westminster. The instructions for recall are sent in the Recall Notice Letter and Recall Response Form. Consumers are directed to call Westminster’s Regulatory Affairs department by phone at: 888-354-9939 (live calls Monday-Friday, 9:00AM – 5:00PM EST with voicemail available 24 hours/day, 7 days/week) or email [email protected] for further queries says the FDA statement.

[Further Reading:Polymerase Chain Reaction]

Tagged with:

About author

Related Articles